Homing of mesenchymal stem cells

mechanistic or stochastic? Implications for targeted delivery in arthritis

Onyedikachi I Eseonu, Cosimo De Bari

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) are multipotent cells with the capacity to undergo chondrogenic differentiation. Systemically administered MSCs have been shown to preferentially accumulate at sites of tissue damage and inflammation, thus MSC-based therapy holds great promise for the treatment of inflammatory diseases such as RA. Modulation of MSC homing may allow targeted delivery of systemically administered MSCs to damaged articular cartilage, where they can suppress immune-mediated cartilage destruction and contribute to cartilage repair via a combination of chondrogenic differentiation and paracrine stimulation of intrinsic residual repair. To harness the potential of MSC homing, a thorough understanding of the mechanism is key. This review discusses current knowledge of the mechanism of MSC homing to injured/inflamed tissue and its implications for targeted MSC-based therapy in arthritis.

Original languageEnglish
Pages (from-to)210-218
Number of pages9
JournalRheumatology
Volume54
Issue number2
Early online date6 Oct 2014
DOIs
Publication statusPublished - 1 Feb 2015

Fingerprint

Mesenchymal Stromal Cells
Arthritis
Cell- and Tissue-Based Therapy
Cartilage
Articular Cartilage
Inflammation

Keywords

  • mesenchymal stem cells
  • rheumatoid arthritis
  • osteoarthritis
  • chemotaxis
  • homing
  • chemokines

Cite this

Homing of mesenchymal stem cells : mechanistic or stochastic? Implications for targeted delivery in arthritis. / Eseonu, Onyedikachi I; De Bari, Cosimo.

In: Rheumatology, Vol. 54, No. 2, 01.02.2015, p. 210-218.

Research output: Contribution to journalArticle

@article{e9de0740dea143f6a425a2701ad60a38,
title = "Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis",
abstract = "Mesenchymal stem cells (MSCs) are multipotent cells with the capacity to undergo chondrogenic differentiation. Systemically administered MSCs have been shown to preferentially accumulate at sites of tissue damage and inflammation, thus MSC-based therapy holds great promise for the treatment of inflammatory diseases such as RA. Modulation of MSC homing may allow targeted delivery of systemically administered MSCs to damaged articular cartilage, where they can suppress immune-mediated cartilage destruction and contribute to cartilage repair via a combination of chondrogenic differentiation and paracrine stimulation of intrinsic residual repair. To harness the potential of MSC homing, a thorough understanding of the mechanism is key. This review discusses current knowledge of the mechanism of MSC homing to injured/inflamed tissue and its implications for targeted MSC-based therapy in arthritis.",
keywords = "mesenchymal stem cells, rheumatoid arthritis, osteoarthritis, chemotaxis, homing, chemokines",
author = "Eseonu, {Onyedikachi I} and {De Bari}, Cosimo",
note = "{\circledC} The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.",
year = "2015",
month = "2",
day = "1",
doi = "10.1093/rheumatology/keu377",
language = "English",
volume = "54",
pages = "210--218",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "OXFORD UNIV PRESS INC",
number = "2",

}

TY - JOUR

T1 - Homing of mesenchymal stem cells

T2 - mechanistic or stochastic? Implications for targeted delivery in arthritis

AU - Eseonu, Onyedikachi I

AU - De Bari, Cosimo

N1 - © The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Mesenchymal stem cells (MSCs) are multipotent cells with the capacity to undergo chondrogenic differentiation. Systemically administered MSCs have been shown to preferentially accumulate at sites of tissue damage and inflammation, thus MSC-based therapy holds great promise for the treatment of inflammatory diseases such as RA. Modulation of MSC homing may allow targeted delivery of systemically administered MSCs to damaged articular cartilage, where they can suppress immune-mediated cartilage destruction and contribute to cartilage repair via a combination of chondrogenic differentiation and paracrine stimulation of intrinsic residual repair. To harness the potential of MSC homing, a thorough understanding of the mechanism is key. This review discusses current knowledge of the mechanism of MSC homing to injured/inflamed tissue and its implications for targeted MSC-based therapy in arthritis.

AB - Mesenchymal stem cells (MSCs) are multipotent cells with the capacity to undergo chondrogenic differentiation. Systemically administered MSCs have been shown to preferentially accumulate at sites of tissue damage and inflammation, thus MSC-based therapy holds great promise for the treatment of inflammatory diseases such as RA. Modulation of MSC homing may allow targeted delivery of systemically administered MSCs to damaged articular cartilage, where they can suppress immune-mediated cartilage destruction and contribute to cartilage repair via a combination of chondrogenic differentiation and paracrine stimulation of intrinsic residual repair. To harness the potential of MSC homing, a thorough understanding of the mechanism is key. This review discusses current knowledge of the mechanism of MSC homing to injured/inflamed tissue and its implications for targeted MSC-based therapy in arthritis.

KW - mesenchymal stem cells

KW - rheumatoid arthritis

KW - osteoarthritis

KW - chemotaxis

KW - homing

KW - chemokines

U2 - 10.1093/rheumatology/keu377

DO - 10.1093/rheumatology/keu377

M3 - Article

VL - 54

SP - 210

EP - 218

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 2

ER -